Table of Content


Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Intended Audience
Methodology and Information Sources
Geographic Breakdown
Analyst’s Credentials
Chapter 2 Summary and Highlights
Chapter 3 Target Diseases and Disorders
Overview of Common Diseases and Disorders for OTC
Cardiovascular Disease
Lifestyle Disorders
Respiratory Disorders
Musculoskeletal Disorders
Mental/Mood Disorders
Gastrointestinal Disorders
Urology Disorders
Chronic Wounds
Chronic Pain
Panic Disorder/Anxiety Disorder
ENT Disorders
Dental Disorders
Eating Disorders
Tobacco Smoking and Associated Diseases
Chronic Diseases: Expanding Horizon for OTC Market
Aging, Gender and Onset of Diseases
Global Demographics
U.S. Demographics
U.S.: Gender, Age and Life Expectancy
European Demographics
Japanese Demographics
Current Challenges and Future Directions
Chapter 4 OTC Drugs and Nutritional Supplements
OTC Therapeutics Overview
Evolution of OTC drugs
Clinical Need of Drugs
Drug-Based Disease Management
Generic Drugs and Disease Management
Generic Drugs vs. Branded Drugs
Continued Resistance to Generics
OTC Drugs and Types
OTC Analgesics/Antipyretics
OTC Antihistamine and Cough and Cold Drugs
OTC Gastrointestinal Products
OTC Dermatological Drugs
OTC Oral Medical Care Products
OTC Eye Care Products
OTC Smoking Cessation Products
Key Marketed OTC Drugs
OTC Dietary Supplements and Types
Eating Disorders
Treatments for Vitamin and Mineral Deficiency
Vitamin and Mineral Supplements (VMS)
Distribution Channel for OTC
Multinational OTC Drug Manufacturers
Drug Stores and Other Chain Store Brands
FMCGs
Practice of OTC Drug Purchase
Regulatory Influence on OTC Drug Market
Market Situation for OTC Drugs and Dietary Supplements
Well-Developed Markets
Developing Markets
Underdeveloped Markets
Therapeutics and Cost Burden
Unmet Need
Current Challenges and Future Developments
Chapter 5 OTC Medical Devices and Diagnostics
Medical Devices, Diagnostics and Disease Management
Clinical and Market Need of OTC Devices and Diagnostics
Types of OTC Devices and Diagnostics
Self-Care Devices and Wearables
Diagnostic Devices and Kits
Key Products
Diagnostic and Monitoring Devices
Therapeutic Devices and Technologies
Remote Patient Monitoring and Home Healthcare
Advantages of Disease Management via Digital Care
Unmet Need
Current Challenges
Future Outlook
Chapter 6 OTC Devices for Treatment Adherence
Treatment Nonadherence
Market Need for OTC Medication Adherence Devices
Hardware-Centric OTC Medication Adherence Devices
Smart Pill Bottle
Automated Pill Dispenser
Electronic Tray
Smart Caps
Other Adherence Devices and Solutions
Key Products
Smart Pill Dispensers, Pillboxes, Organizers, Smart Pill Cap and Bottle Systems
Other OTC Adherence Devices
Current Challenges
Future Developments
Chapter 7 Market Size and Growth Analysis
Market Size and Growth Analysis
Market Size and Growth Analysis, by Region
Market Size and Growth Analysis, by Product Segment
Market Size and Growth Analysis, by Disease Type
Market Growth Drivers and Restraints
Market Growth Drivers
Market Restraints
Regulatory Impact on the OTC Market
Brexit Effect on the OTC Market in Europe
SWOT Analysis of OTC Market
Chapter 8 Competitive Landscape in the OTC Drugs, Medical Devices and Diagnostics Market
Competitive Landscape: Disease Treatment and Management with OTC Drugs, Medical Devices and Diagnostic Technologies
Chapter 9 Strategies in the OTC Drugs, Medical Devices and Diagnostics Market
Consolidation in the OTC Drugs and Devices Market
Mergers and Acquisitions in the OTC Drugs, Medical Devices and Diagnostics Market
OTC Drugs and Nutritional Products (Vitamin and Mineral Supplements)
OTC Medical Devices and Diagnostics
Recent Mergers and Acquisitions
OTC Medical Devices and Diagnostics
OTC Drugs and Nutritional Products (Vitamin and Mineral Supplements)
Minority Stakes and Future Options to Acquire
Future Strategic Landscape
Chapter 10 Regulatory Structure: Pharmaceuticals, Medical Devices and Diagnostics
Regulatory Background
Regulatory Systems for Medical Devices, by Region
U.S.
European Union
Japan
Regulatory Systems for Pharmaceuticals, by Region
U.S.
Europe
Japan
Rules and Regulations for OTC Drugs and Dietary Supplements
Regulations for OTC drugs
Regulations for Dietary Supplements
Chapter 11 Pricing and Reimbursement: Pharmaceuticals, Medical Devices and Diagnostics
Pricing and Reimbursement Background
Pricing and Reimbursement for Medical Devices, by Region
U.S.
Europe
Japan
Other Asia-Pacific
Pricing and Reimbursement for Pharmaceuticals, by Region
U.S.
Europe
Japan
Chapter 12 Conclusions-Outlook for OTC Drugs, Medical Devices and Diagnostics
Major Developments Influencing the Market
Technological Developments
Demographic and Economic Trends
Changing Structure of the Healthcare Industry
Lifestyle Medicine
Patient-Centric Programs
Prevalence of Self-Care
Burden on Public Health System
Retain Market Leadership
Long-Term Outlook
Chapter 13 Company Profiles
3M
ABBOTT LABORATORIES
ABBVIE INC.
ACADIA PHARMACEUTICAL
ACORDA THERAPEUTICS
ACTAVIS PLC
ACTUALMEDS
ADHERIUM
AETHLON MEDICAL INC.
AGENUS
AKRON
ALACER CORP.
ALCON INC.
ALERE INC.
ALFRESA PHARMA CORP.
ALIPHCOM INC.
ALIVECOR
ALKALON A/S
ALKERMES
ALLERGAN
ALLIANCE HEALTHCARE
AMGEN INC.
AMIKO
AMNEAL PHARMACEUTICALS
ANAVEX LIFE SCIENCES
ANI PHARMACEUTICALS
ANIMAS (A SUBSIDIARY OF JOHNSON & JOHNSON)
APOTEX
ARCHOS
ARENA PHARMACEUTICALS
ARRAY BIOPHARMA
ASAHI KASAI CORP.
ASLAN PHARMACEUTICALS
ASPEN PHARMACARE
ASSERTIO THERAPEUTICS, INC.
ASTELLAS PHARMA INC.
ASTRAZANECA PLC
ATHERSYS
AUDENTES THERAPEUTICS
AXIOBIONICS
AXSOME THERAPEUTICS
BAUSCH & LOMB
BAUSCH HEALTH
BAXTER INTERNATIONAL INC.
BAYER AG
BEIGENE
BESPAK EUROPE
BIOMERIEUX
BIOSENSICS
BIOSERENITY
BIOTRICITY
BIOTRONIK
BIOVOTION
BIOXCEL THERAPEUTICS
BODYTEL
BOEHRINGER INGELHEIM
BOSTON SCIENTIFIC
BRAINMARC
BRISTOL-MYERS SQUIBB
BTS BIOENGINEERING
CARDIOMEMS INC. (A SUBSIDIARY OF ST. JUDE)
CARMA LABORATORIES, INC.
CELGENE
CHATTEM INC.
CHUGAI PHARMACEUTICALS CO. LTD.
CILAG AG
CIPLA
CLEVELAND MEDICAL DEVICES
COLGATE-PALMOLIVE CO.
CONNECTEDHEALTH PTE. LTD.
CONSORT MEDICAL
CORBUS PHARMACEUTICALS
CSPC PHARMACEUTICAL GROUP
DAIICHI SANKYO
DERMA SCIENCES
DEXCOM INC.
DR. REDDY’S LABORATORIES LTD.
EARLYSENSE
EISAI
ELI LILLY AND CO.
EMPATICA
ENDO INTERNATIONAL
ENDOCEUTICS INC.
ENDOTRONIX
ENTRA HEALTH SYSTEMS
ERYTECH PHARMA
ESTEVE
EVERIST HEALTH
EYESCIENCE LABS
FERTIN PHARMA A/S
GABA SCHWEIZ
GALDERMA S.A.
GEMINI PHARMACEUTICALS INC.
GENOMMA LAB INTERNATIONAL
GENOMMA LAB USA
GILEAD SCIENCES
GLAXOSMITHKLINE PLC
GLOOKO INC.
GLUCOVISTA INC.
HEALTH CARE ORIGINALS
HIKMA PHARMACEUTICALS
HISAMITSU PHARMACEUTICAL CO. INC.
HOCOMA
IHEALTH LAB INC.
IMMUNOMEDICS
IMPACT SPORTS TECHNOLOGIES
IMPAK HEALTH
INFOBIONIC INC.
INSULET CORP.
INTELESENS
INTRA-CELLULAR THERAPIES
IOVANCE BIOTHERAPEUTICS
IPSEN S.A.
JAN MEDICAL INC.
JIANGSU HENGRUI MEDICINE
JOHNSON & JOHNSON
KOWA CO. LTD.
KYOWA HAKKO KIRIN
LAKE CONSUMER PRODUCTS INC.
LES LABORATOIRES SERVIER
LIVANOVA PLC
LUNDBECK
LUPIN
MALLINCKRODT PLC
MANX HEALTHCARE LTD.
MCM KLOSTERFRAU VERTRIEBS GMBH (KLOSTERFRAU HEALTHCARE GROUP)
MEDA AB
MEDMINDER
MEDTRONIC
MEDTRONIC MINIMED INC. (A SUBSIDIARY OF MEDTRONIC)
MELALEUCA INC.
MENARINI
MERCK
MERZ PHARMA
MIO GLOBAL
MITSUBISHI TANABE PHARMA
MOCHIDA PHARMACEUTICAL CO. LTD.
MYCARDIO LLC
MYLAN INC.
NEMAURA MEDICAL INC.
NEOFECT CO. LTD.
NEUROCRINE BIOSCIENCES
NEUROMETRIX INC.
NEUROVIGIL INC.
NEUTROGENA CORP.
NORTHEAST PHARMACEUTICAL GROUP CO. LTD.
NOVARTIS
NOVASOM INC.
NOVO NORDISK
NOW FOODS
NUCANA
OMADA HEALTH INC.
OMNICELL INC.
OMRON CORP.
ONO PHARMACEUTICAL CO. LTD.
ORION PHARMA LTD.
ORPYX MEDICAL TECHNOLOGIES
OTSUKA PHARMACEUTICALS
PACIRA PHARMACEUTICALS INC.
PERRIGO PLC
PFIZER
PGT HEALTHCARE (DIVISION OF PROCTER & GAMBLE)
PHARMAVITE LLC
PHILOSYS
PIERRE FABRE PHARMACEUTICALS INC.
PIRAMAL HEALTHCARE LTD.
POLAR ELECTRO OY
PRESTIGE BRANDS HOLDINGS INC.
PREVENTICE INC.
PRIZM MEDICAL INC.
PROPELLER HEALTH
PROTEOSTASIS THERAPEUTICS
PROTEUS DIGITAL HEALTH INC.
QARDIO
RECKITT BENCKISER (NORTH AMERICA) INC.
RECKITT BENCKISER PLC.
RECORDATI PHARMA GMBH
REHAB-ROBOTICS (A MEMBER OF VINCENT MEDICAL HOLDINGS)
REVOLYMER (U.K.) LTD
REXAHN PHARMACEUTICALS
ROCHE
SAGE PRODUCTS LLC
SAGE THERAPEUTICS
SANOFI
SAREPTA THERAPEUTICS
SATO PHARMACEUTICAL CO. LTD.
SENSE4CARE
SENSEONICS HOLDINGS
SENTICARE INC.
SHAKLEE CORP.
SHANGHAI PHARMACEUTICALS HOLDING
SHIONOGI AND CO. LTD.
SILVERGENS
SPROUTLING INC. (ACQUIRED BY MATTEL)
ST. JUDE MEDICAL (A SUBSIDIARY OF ABBOTT LABORATORIES)
STADA ARZNEIMITTEL AG
SUMITOMO DAINIPPON PHARMA CO. LTD.
SUN PHARMACEUTICAL INDUSTRIES
SWISSE WELLNESS PTY LTD.
TAISHO PHARMACEUTICAL HOLDINGS
TAISHO PHARMACEUTICAL
TAKEDA PHARMACEUTICAL CO. LTD.
TCR2 THERAPEUTICS
TEVA PHARMACEUTICAL INDUSTRIES
TISSO NATURPRODUKTE GMBH
TOWERVIEW HEALTH INC.
TRANSLATE BIO
TYME TECHNOLOGIES
UCB
UNILIFE CORP.
VAICA
VERTEX PHARMACEUTICAL
VITAL CONNECT
WELLSPRING PHARMACEUTICAL CORP.
WEST PHARMACEUTICAL SERVICES INC.
WINMEDICAL SRL
YBRAIN
YPSOMED HOLDING AG
ZEAVISION LLC
ZOGENIX INC.
ZYDUS CADILA
Chapter 14 Appendix A: List of Acronyms
Chapter 15 Appendix B: Professional Organizations
American Heart Association
Center for Drug Evaluation and Research (CDER)
Center for Devices and Radiological Health (CDRH)
Centers for Medicare and Medicaid Services (CMS)
European Databank for Medical Devices (EUDAMED)
Food and Drug Administration (FDA or U.S. FDA)
Hormone Foundation
International Diabetes Federation (IDF)
International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
Network for Excellence in Health Innovation (NEHI)
National Center for Biotechnology Information (NCBI)
National Institute of Aging (NIA)
Pharmaceuticals and Medical Devices Agency (PMDA)
World Cancer Research Fund International
World Health Organization (WHO)



List of Figures


Summary Figure : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, 2018-2024
Figure 1 : Global Incidence Share of Hypertension, by Patient Group Type, 2019
Figure 2 : Global Prevalence of Angina Pectoris and Stroke (Survivors), 2004-2030
Figure 3 : Global Prevalence of Congestive Heart Failure and Stroke, 2004-2030
Figure 4 : Trends in Obesity Composition of the World’s Population, 2012-2025
Figure 5 : Obesity and Severe Obesity vs. General Population in U.S., 2018 and 2025
Figure 6 : Global Share of Diabetes, by Type
Figure 7 : Global Prevalence of Diabetes, by Type, 2018 and 2040
Figure 8 : Global Symptomatic Prevalence of Key Musculoskeletal Disorders, 2012-2025
Figure 9 : Global Deaths Share, by Various Musculoskeletal Disorders, 2015
Figure 10 : Global Deaths from Digestive Diseases, by Region, 2015-2025
Figure 11 : Global Deaths Share, by Various Chronic Disease Types, 2018
Figure 12 : Global DALYs Share, by Various Chronic Disease Types, 2018
Figure 13 : Estimated World Population and Annual Growth, by Age Group, 2000-2030
Figure 14 : World Population, by Country/Region, 2000-2030
Figure 15 : U.S. Population Estimates and Projections, by Age Group, 2000-2030
Figure 16 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, 2005-2020
Figure 17 : European Population Estimates and Projections, by Age Group, 2000-2030
Figure 18 : Japanese Population Estimates and Projections, by Age Group, 2000-2030
Figure 19 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, 2018-2024
Figure 20 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Product Segment, 2018-2024
Figure 21 : Global Market Share for OTC Drugs, Medical Devices and Diagnostics, by Product Segment, 2019
Figure 22 : Global Market Share for OTC Drugs and Nutritional Supplements, by Therapeutic Classification, 2019
Figure 23 : Global Market Share for Device Technologies, by Device Type, 2019
Figure 24 : Global Market for OTC Treatment Adherence Devices, 2018-2024
Figure 25 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Disease Type, 2018-2024
Figure 26 : Trends in Per Capita Real Gross Domestic Product Growth, by Region, 2015-2018

 

List of Tables


Summary Table : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, Through 2024
Table 1 : Global Incidence Share of Hypertension, by Patient Group Type, 2019
Table 2 : Global Prevalence of Angina Pectoris and Stroke (Survivors), Through 2030
Table 3 : Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
Table 4 : Structural Heart Disease Management Through Medication
Table 5 : BMI Calculation
Table 6 : BMI Categories Based on Increasing Health Risks
Table 7 : Trends in Obesity Composition of the World’s Population, Through 2025
Table 8 : Obesity and Severe Obesity vs. General Population in U.S., Through 2025
Table 9 : Global Share of Diabetes, by Type
Table 10 : Global Prevalence of Diabetes, by Type, Through 2040
Table 11 : Global Symptomatic Prevalence of Key Musculoskeletal Disorders, Through 2025
Table 12 : Global Deaths, by Various Musculoskeletal Disorders, Through 2030
Table 13 : Global Deaths from Digestive Diseases, by Region, Through 2025
Table 14 : Global Deaths Share, by Various Chronic Disease Types, 2018
Table 15 : Global DALYs Share, by Various Chronic Disease Types, 2018
Table 16 : Estimated World Population and Annual Growth, by Age Group, Through 2030
Table 17 : World Population, by Country/Region, Through 2030
Table 18 : U.S. Population Estimates and Projections, by Age Group, Through 2030
Table 19 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, Through 2020
Table 20 : European Population Estimates and Projections, by Age Group, Through 2030
Table 21 : Japanese Population Estimates and Projections, by Age Group, Through 2030
Table 22 : Key Marketed OTC Drugs
Table 23 : Cardiac Monitoring Devices and Technologies, by Company
Table 24 : Key Continuous Glucose Monitoring Devices and Technologies, by Company
Table 25 : Sleep-Monitoring Devices and Technologies, by Company
Table 26 : Key Vital Sign and Activity Monitoring Devices and Technologies, by Company
Table 27 : Pain Management Devices and Technologies, by Company
Table 28 : Drug Delivery Devices and Technologies, by Company
Table 29 : Insulin Delivery Devices and Technologies, by Company
Table 30 : Global Medication Adherence Percentages, by Chronic Diseases
Table 31 : Smart Pill Dispensers, Pillboxes and Organizers, by Company
Table 32 : Medication Tracking Devices and Apps, by Company
Table 33 : Pill Organizer and Reminder Systems, by Company
Table 34 : Smart Pill Cap and Bottle Systems, by Company
Table 35 : Other Medication Adherence Solutions, by Company
Table 36 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, Through 2024
Table 37 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Product Segment, Through 2024
Table 38 : Global Market for OTC Treatment Adherence Devices, Through 2024
Table 39 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Disease Type, Through 2024
Table 40 : SWOT Analysis of the OTC Drugs, Medical Devices and Diagnostics Market
Table 41 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Company, 2019
Table 42 : Key Strategic Deals in the OTC Medical Devices and Diagnostics Market, by Company, 2012-2019
Table 43 : Key Strategic Deals in OTC Drugs and Nutritional Product/Supplement Market, by Company, 2016-2019
Table 44 : Key Strategic Deals for Business Units, Minority Stakes and Future Options to Acquire in the OTC Market, by Company, 2016-2019
Table 45 : Differences in Regulatory Approval in the U.S. and Europe
Table 46 : Trends in Per Capita Real Gross Domestic Product Growth, by Region, 2015-2018
Table 47 : List of Acronyms used in OTC Drugs, Medical Devices and Diagnostics